12 Health Care Stocks Moving In Friday's After-Market Session

GainersSharps Technology (NASDAQ:STSS) shares rose 50.5% to $0.32 during Friday's after-market session. The market value of their outstanding shares is at $5.0 million. Cyclacel Pharmaceuticals (NASDA

BenzingaMay 24 16:31 ET

BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment With NurOwn

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, will present new biomarker data suggesting that ALS patients may benefit from longer-term treatment with debamestrocel (NurOwn®).

PRNewswireMay 20 06:00 ET

Brainstorm Cell Therapeutics | 10-Q: Quarterly report

SEC announcementMay 14 17:07 ET · Announcements

Express News | Brainstorm Cell Q1 2024 Adj EPS $(0.05) Beats $(0.07) Estimate

BenzingaMay 14 16:53 ET

Express News | Brainstorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

ReutersMay 14 16:30 ET

Express News | Brainstorm Cell Therapeutics Shares Are Trading Lower After the Company Announced It Received a Letter From the Nasdaq Indicating That It Did Not Regain Compliance With the Minimum Bid Price Requirement

BenzingaMay 6 11:23 ET